483
Manhattan Reproductive Medicine, PCManhattan Reproductive Medicine, PC – FDA 483, Jun 29, 2022
Record Details
Manhattan Reproductive Medicine, PC, a human reproductive tissue establishment, was cited for deficiencies during an FDA inspection. The firm failed to adequately screen oocyte donors for communicable disease risk factors, specifically Zika Virus, due to an incomplete questionnaire. Additionally, the firm lacked established written procedures for utilizing its electronic donor screening system.
View Company Profile
ID · db28ec06-ca81-490b-b6c5-214c9d25750d
Other documents for Manhattan Reproductive Medicine, PC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.